Episode Details

Orca Bio just landed a major win: FDA approval for its groundbreaking cell therapy targeting blood cancer patients post-stem cell transplant. Designed to rebuild blood and immune systems while slashing chronic graft-versus-host disease, this therapy could save lives. The green light means big expansion—especially in Sacramento, where their manufacturing hub is growing fast. Deep ties with UC Davis Medical Center were key to development, and now the company is hiring urgently to scale production of this complex, life-saving treatment, boosting Sacramento’s biotech scene with high-demand, cutting-edge jobs.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/1a00c6e402a74e80